Cellectis (LTS:0WA2) ROE % Adjusted to Book Value : 19.50% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cellectis ROE % Adjusted to Book Value?

Cellectis's ROE % for the quarter that ended in Dec. 2024 was 18.72%. Cellectis's PB Ratio for the quarter that ended in Dec. 2024 was 0.96. Cellectis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 19.50%.

Cellectis ROE % Adjusted to Book Value Historical Data

The historical data trend for Cellectis's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectis ROE % Adjusted to Book Value Chart

Cellectis Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.73

-27.38

-78.59

-36.18

-36.06

Cellectis Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-75.94	12.00	-70.70	-38.84	19.50

Competitive Comparison of Cellectis's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Cellectis's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellectis's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectis's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cellectis's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Cellectis ROE % Adjusted to Book Value Calculation

Cellectis's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-34.62%	/	0.96
	=	-36.06%

Cellectis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	18.72%	/	0.96
	=	19.50%

Cellectis ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cellectis's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellectis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectis SA (LTS:0WA2) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CLLS:USA ALCLS:France ZVAA:Germany

Address

8, rue de la Croix Jarry, Paris, FRA, 75013

Website

https://www.cellectis.com

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Cellectis Headlines

No Headlines